History of Nomegestrol acetate

Nomegestrol was patented in 75, and NOMAC, under the developmental code name TX-066, was initially described in typically the literature in 1983. It was developed by Theramex Laboratories, a pharmaceutical business in Monaco (a satellite tv country of France). Typically the medication was first launched in Europe alone or even in combination with estradiol under typically the respective brand names Lutenyl plus Naemis for that treatment of gynecological disorders and menopausal symptoms in 1986, and was subsequently developed in addition to approved in 2011 within Europe as a birth control pill along with estradiol under the brand title Zoely. As Zoely, NOMAC has been studied in more than 4, 000 women as a technique of birth handle.